ImmunoGen
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. ImmunoGen's past years’ income statements indicate that its last revenue has compared to the previous period by 0% to $108,782,000. Profit margin reached -205%. Total operating expenses were $329,499,000.
Profit Margin
| 2015 | 85.54M | -60.73M | -71.01% |
|---|---|---|---|
| 2016 | 60.00M | -143.65M | -239.42% |
| 2016 | 48.62M | -156.73M | -322.31% |
| 2017 | 115.44M | -96.01M | -83.17% |
| 2018 | 53.81M | -167.87M | -311.94% |
| 2019 | 82.27M | -122.09M | -148.4% |
| 2020 | 132.29M | -66.68M | -50.4% |
| 2021 | 108.78M | -222.92M | -204.93% |
| 2022 | 108.78M | -222.92M | -204.93% |
0A8K.L Income Statement (2014 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 108.78M | 108.78M | 132.29M | 82.27M | 53.81M | 115.44M | 48.62M | 60.00M | 85.54M |
Cost of revenue | 176K | 176K | 114.59M | 114.52M | 173.88M | 139.73M | 141.31M | 146.91M | 111.76M |
Gross profit | 108.60M | 108.60M | 17.70M | -32.25M | -120.07M | -24.29M | -92.68M | -86.91M | -26.22M |
Operating exp. | |||||||||
Research and development | 213.37M | 213.37M | 114.59M | 114.52M | 173.88M | 139.73M | 141.31M | 146.91M | 111.76M |
Selling and marketing | 0 | 72.31M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 329.49M | 329.49M | 153.19M | 153.01M | 210.60M | 173.65M | 43.54M | 183.83M | 139.99M |
Operating income | -220.89M | -220.89M | -135.48M | -92.17M | -160.47M | -58.98M | -131.21M | -123.82M | -54.45M |
Other income (expenses), net | 3.34M | -818K | -21.99M | -11.96M | -361K | -37.03M | -25.52M | -19.82M | -6.28M |
Income before tax | -221.71M | -221.71M | -44.37M | -104.13M | -167.87M | -96.01M | -156.73M | -143.65M | -60.73M |
Income tax expense | 1.21M | 1.21M | 22.31M | 17.96M | 7.39M | 37.03M | 0 | 19.82M | 6.28M |
Net income | -222.92M | -222.92M | -66.68M | -122.09M | -167.87M | -96.01M | -156.73M | -143.65M | -60.73M |
Earnings per share | |||||||||
Basic EPS | -0.88 | -0.88 | -0.38 | -0.82 | -1.2 | -0.98 | -1.8 | -1.65 | -0.71 |
Diluted EPS | -0.88 | -0.88 | -0.38 | -0.82 | -1.2 | -0.98 | -1.8 | -1.65 | -0.71 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |